Quest Diagnostics Inc vs Vale SA — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.23B), while Vale SA trades at $14.39 (market cap $62.26B). The key difference: Vale SA is far larger — about 2.4× Quest Diagnostics Inc's market cap, and Vale SA pays the higher dividend (8.12%). Which is the better fit depends on your goals.
| DGX | VALE | |
|---|---|---|
Market Cap | $26.23B | $62.26B |
Sector | Health | Basic Materials |
52-Week High | $238.50 | $17.82 |
52-Week Low | $173.49 | $9.71 |
Enterprise Value | $31.99B | $78.50B |
Dividend Yield | 1.45% | 8.12% |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →